Novel Orexin Drug Normalizes Wakefulness in Narcolepsy Type 1

By News Health
5 hours Ago

(MedPage Today) — CHICAGO — Novel orexin receptor 2 agonist oveporexton normalized wakefulness for most people with narcolepsy type 1 in two randomized phase III trials.
Mean sleep latency across four, 40-minute Maintenance of Wakefulness…

Source link : https://www.medpagetoday.com/meetingcoverage/chest/118089

Author :

Publish date : 2025-10-22 19:27:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Bad Gums Tied to Big Brain Risks

Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer

'Alternative' to CDC's Flagship Journal in the Works

Can Steroids Be Stopped in Lupus Nephritis? Yes, and Here's How

A Peek Inside the Blue Medical Tent That Has Become a Fixture on NFL Sidelines

Ob/Gyns Urged to Fight Contraception Misinformation